Effect of Tanshinone IIA on Gut Microbiome in Diabetes-Induced Cognitive Impairment

Diabetes-induced cognitive impairment (DCI) presents a major public health risk among the aging population. Previous clinical attempts on known therapeutic targets for DCI, such as depleted insulin secretion, insulin resistance, and hyperglycaemia have delivered poor patient outcomes. However, recen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yanfang, Zhou, Xian, Wang, Chenxiang, Zhang, Jialin, Chang, Dennis, Liu, Wenjing, Zhu, MingXing, Zhuang, Shuting, Shi, Hong, Wang, Xiaoning, Chen, Yong, Cheng, Zaixing, Lin, Yanxiang, Nan, Lihong, Sun, Yibin, Min, Li, Liu, Jin, Chen, Jianyu, Zhang, Jieping, Huang, Mingqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309808/
https://www.ncbi.nlm.nih.gov/pubmed/35899118
http://dx.doi.org/10.3389/fphar.2022.890444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309808/
https://www.ncbi.nlm.nih.gov/pubmed/35899118
http://dx.doi.org/10.3389/fphar.2022.890444

Ejemplares similares